Clinical trial
Efficacy of Ivermectin in Outpatients With Non-severe COVID-19: A Randomized Controlled Trial
NCT04834115 is registered in ClinicalTrials.gov with Universidad Nacional de Asunción as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Ivermectin in Outpatients With Non-severe COVID-19: A Randomized Controlled Trial
- Lead sponsor
- Universidad Nacional de Asunción
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- November 17, 2020
- Completion date
- May 30, 2021
- Enrollment
- 400 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
coronavirus infection, covid19